![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
FDA Approves New Drug For DMD Patients Despite Its Ineffectiveness (The Young Turks) View |
![]() |
Summit Therapeutics passes “important milestone” with FDA approval (Proactive Investors) View |
![]() |
Gene therapy trial in muscular dystrophy patients shows exciting results (CNBC Television) View |
![]() |
TALKING ABOUT THE DUCHENNE DRUG APPROVAL (Dylan Miceli-Nelson) View |
![]() |
Is Eteplirsen Effective in Non-ambulatory Duchenne Patients (Rare Disease Report) View |
![]() |
How Should Investors Think About Sarepta Therapeutics From Here (The Motley Fool) View |
![]() |
To Janet Woodcock, FDA Director of CDER Concerning Accelerated Approval for Eteplirsen (Ricky Tsang) View |
![]() |
(Annamaria Scaccia) View |
![]() |
Sarepta Therapeutics Chart Analysis – Explosive Options (Explosive Options) View |
![]() |
Cell and Gene Therapy Update Episode 2 (LucidQuest) View |